• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利什曼病

Leishmaniasis.

作者信息

Grevelink S A, Lerner E A

机构信息

Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Am Acad Dermatol. 1996 Feb;34(2 Pt 1):257-72. doi: 10.1016/s0190-9622(96)80121-6.

DOI:10.1016/s0190-9622(96)80121-6
PMID:8642091
Abstract

Leishmaniasis is a protozoan disease whose diverse clinical manifestations are dependent both on the infecting species of Leishmania and on the immune response of the host. Transmission of the disease occurs through the bite of a sand fly infected with Leishmania parasites. Infection may be restricted to the skin in cutaneous leishmaniasis, limited to the mucous membranes in mucosal leishmaniasis, or spread throughout the reticuloendothelial system in visceral leishmaniasis or kala azar. Three rare clinical variants of cutaneous leishmaniasis include diffuse cutaneous leishmaniasis, leishmaniasis recidivans, and post-kala-azar dermal leishmaniasis.

摘要

利什曼病是一种原生动物疾病,其多样的临床表现既取决于感染的利什曼原虫种类,也取决于宿主的免疫反应。该疾病通过感染利什曼原虫寄生虫的白蛉叮咬传播。在皮肤利什曼病中,感染可能局限于皮肤;在黏膜利什曼病中,感染局限于黏膜;在内脏利什曼病或黑热病中,感染则会扩散至整个网状内皮系统。皮肤利什曼病的三种罕见临床变体包括弥漫性皮肤利什曼病、复发性利什曼病和黑热病后皮肤利什曼病。

相似文献

1
Leishmaniasis.利什曼病
J Am Acad Dermatol. 1996 Feb;34(2 Pt 1):257-72. doi: 10.1016/s0190-9622(96)80121-6.
2
PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.合并感染HIV的利什曼病患者的皮肤利什曼病后皮肤黏膜病变及其他皮肤病变:与免疫反应相关的临床表现综述
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3258. doi: 10.1371/journal.pntd.0003258. eCollection 2014.
3
Leishmaniasis as an emerging infection.利什曼病作为一种新发感染性疾病。
J Investig Dermatol Symp Proc. 2001 Dec;6(3):175-82. doi: 10.1046/j.0022-202x.2001.00038.x.
4
[Leishmaniasis in children. Recent progress].[儿童利什曼病。近期进展]
Bol Med Hosp Infant Mex. 1984 Jul;41(7):356-62.
5
Cutaneous Manifestations of Human and Murine Leishmaniasis.人类和鼠类利什曼病的皮肤表现
Int J Mol Sci. 2017 Jun 18;18(6):1296. doi: 10.3390/ijms18061296.
6
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).皮肤利什曼病和内脏利什曼病后皮肤利什曼病(PKDL)的免疫发病机制。
Front Cell Infect Microbiol. 2021 Jun 8;11:685296. doi: 10.3389/fcimb.2021.685296. eCollection 2021.
7
[Leishmaniasis].[利什曼病]
Ugeskr Laeger. 2000 Nov 13;162(46):6203-7.
8
[Leishmaniasis with cutaneous and visceral involvement in a 13-month old boy].[一名13个月大男童的皮肤型和内脏型利什曼病]
Klin Padiatr. 2000 Sep-Oct;212(5):266-7. doi: 10.1055/s-2000-9685.
9
Leishmania and HIV co-infection: dermatological manifestations.利什曼原虫与人类免疫缺陷病毒合并感染:皮肤表现
Ann Trop Med Parasitol. 2003 Oct;97 Suppl 1:107-14. doi: 10.1179/000349803225002589.
10
[Histology of cutaneous leishmaniasis].[皮肤利什曼病的组织学]
Ann Dermatol Venereol. 2011;138(4):354-6. doi: 10.1016/j.annder.2010.10.018. Epub 2010 Nov 24.

引用本文的文献

1
Metagenomic next-generation sequencing assists in the diagnosis of visceral leishmaniasis in non-endemic areas of China.宏基因组下一代测序有助于中国非流行地区内脏利什曼病的诊断。
Front Cell Infect Microbiol. 2025 Feb 6;15:1517046. doi: 10.3389/fcimb.2025.1517046. eCollection 2025.
2
Efficacy of vaccines based on chimeric or multiepitope antigens for protection against visceral leishmaniasis: A systematic review.基于嵌合或多表位抗原的疫苗预防内脏利什曼病的疗效:一项系统评价。
PLoS Negl Trop Dis. 2024 Dec 31;18(12):e0012757. doi: 10.1371/journal.pntd.0012757. eCollection 2024 Dec.
3
Antileishmanial effects of γCdcPLI, a phospholipase A2 inhibitor from Crotalus durissus collilineatus snake serum, on Leishmania (Leishmania) amazonensis.
γCdcPLI,一种来自响尾蛇(Crotalus durissus collilineatus)蛇血清的磷脂酶 A2 抑制剂,对利什曼原虫(Leishmania)亚马逊亚种的抗利什曼原虫作用。
Mem Inst Oswaldo Cruz. 2023 Nov 27;118:e220225. doi: 10.1590/0074-02760220225. eCollection 2023.
4
Case Report: Diffuse Cutaneous Leishmaniasis Successfully Treated with a Combination of Oral Rifampicin and Fluconazole.病例报告:口服利福平联合氟康唑成功治疗弥漫性皮肤利什曼病。
Am J Trop Med Hyg. 2023 Jul 10;109(2):315-318. doi: 10.4269/ajtmh.23-0170. Print 2023 Aug 2.
5
Distribution and Risk of Cutaneous Leishmaniasis in Khyber Pakhtunkhwa, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省皮肤利什曼病的分布与风险
Trop Med Infect Dis. 2023 Feb 20;8(2):128. doi: 10.3390/tropicalmed8020128.
6
Comparison of Efficacy of Two Different Concentrations of Intralesional Amphotericin B in the Treatment of Cutaneous Leishmaniasis; A Randomized Controlled Trial.两种不同浓度的两性霉素B皮损内注射治疗皮肤利什曼病的疗效比较:一项随机对照试验
Indian Dermatol Online J. 2019 Nov 1;10(6):627-631. doi: 10.4103/idoj.IDOJ_470_18. eCollection 2019 Nov-Dec.
7
Microneedle-Based Delivery of Amphotericin B for Treatment of Cutaneous Leishmaniasis.基于微针的两性霉素B递送用于治疗皮肤利什曼病
Biomed Microdevices. 2019 Jan 7;21(1):8. doi: 10.1007/s10544-018-0355-8.
8
Histopathological characteristics of cutaneous lesions caused by Leishmania Viannia panamensis in Panama.巴拿马泛美利什曼原虫引起的皮肤病变的组织病理学特征
Rev Inst Med Trop Sao Paulo. 2018;60:e8. doi: 10.1590/s1678-9946201860008. Epub 2018 Feb 15.
9
Epidemiological Trends of Cutaneous Leishmaniasis in Al-Madinah Al-Munawarah Province, Western Region of Saudi Arabia.沙特阿拉伯西部地区麦地那省皮肤利什曼病的流行病学趋势
J Glob Infect Dis. 2017 Oct-Dec;9(4):146-150. doi: 10.4103/jgid.jgid_16_17.
10
Lupoid cutaneous Leishmaniasis: A Report of Three Cases from Nonendemic Area.狼疮样皮肤利什曼病:非流行区3例报告。
Indian J Dermatol. 2017 Sep-Oct;62(5):548. doi: 10.4103/ijd.IJD_420_16.